Detection of Glycoprotein V/CD42d in Human CD41+ Platelets by Flow Cytometry.
Human blood‑derived CD41+ platelets were stained with Mouse Anti-Human Glycoprotein V/CD42d Monoclonal Antibody (Catalog # MAB4249, filled histogram) or isotype control antibody (Catalog # MAB002, open histogram), followed by Allophycocyanin-conjugated Anti-Mouse IgG F(ab')2 Secondary Antibody (Catalog # F0101B).
Preparation and Storage
Reconstitute at 0.5 mg/mL in sterile PBS.
Reconstitution Buffer Available
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Glycoprotein V/CD42d
GPV (platelet glycoprotein V; designated CD42d) is an 83 kDa type I transmembrane (TM) glycoprotein of the leucine‑rich repeat (LRR) family (1, 2). It is expressed exclusively within the platelet / megakaryocyte lineage, where it noncovalently interacts with other platelet TM LRR proteins, GPIb alpha / beta and GPIX, at a ratio of one GPV to two of each other subunit (2). The GPI‑V‑IX complex tethers platelets to von Willebrand factor on the surface of injured endothelial cells. Absence of the complex results in Bernard‑Soulier syndrome, a rare bleeding disorder (1‑3). The human GPV cDNA encodes a 560 amino acid (aa) protein with a 16 aa signal sequence, a 507 aa extracellular domain (ECD) containing 15 LRR, a 21 aa TM sequence, and a short (16 aa) cytoplasmic tail that binds calmodulin in resting, but not activated platelets. The human GPV ECD shares 70%, 71% and 81% aa identity with mouse, rat and equine GPV, respectively. GPV can form soluble fragments of 80 kDa by ADAM10 or ADAM17 cleavage after P507, or 69 kDa by thrombin cleavage after R476 (1, 4, 5). High circulating soluble GPV may be an indicator of platelet activation, but may also be caused by high doses of aspirin (6‑8). The function of GPV is not entirely clear. Deletion of GPV in mice does not produce any obvious change to surface expression or function of GPIb and GPIX, but surface expression of GPV requires GPIb (9, 10). Deletion studies also indicate that GPV may play a minor role in collagen adhesion, and may modify platelet aggregation in response to thrombin (3, 11‑15).
Lanza, F. et al. (1993) J. Biol. Chem. 268:20801.
Hickey, M.J. et al. (1993) Proc. Natl. Acad. Sci. USA 90:8327.
Ozaki, Y. et al. (2005) J. Thromb. Haemost. 3:1745.
Rabie, T. et al. (2005) J. Biol. Chem. 280:14462.
Gardiner, E.E. et al. (2007) J. Thromb. Haemost. 5:1530.
Wolff, V. et al. (2005) Stroke 36:e17.
Javela, K. et al. (2005) Transfusion 45:1504.
Aktas, B. et al. (2005) J. Biol. Chem. 280:39716.
Kahn, M.L. (1999) Blood 94:4112.
Strassel, C. et al. (2004) Eur. J. Biochem. 271:3671.
Nonne, C. et al. (2008) J. Thromb. Haemost. 6:210.
Moog, S. et al. (2001) Blood 98:1038.
Ramakrishnan, V. et al. (1999) Proc. Natl. Acad. Sci. USA 96:13336.
Have you used Human Glycoprotein V/CD42d Antibody?
Submit a review and receive a $25US/€18/£15/$25CAN amazon gift card if you include an image - $10US/€7/£6/$10CAN Amazon card for reviews without an image. Limited to verified customers in USA, Canada and Europe.